Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy

Diabetologia

Volumn 51, Issue 6, 2008, Pages 1062-1067

  Wang, G ^a   Lai, F M M ^a   Lai, K B ^a   Chow, K M ^a   Kwan, C H B ^a   Li, K T P ^a   Szeto, C C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ACE2; Diabetes mellitus; Urinalysis

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; LISINOPRIL; MESSENGER RNA; PERINDOPRIL; RAMIPRIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINARY EXCRETION;

AGED; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 43049103449     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-0988-x     Document Type: Article

References (32)

1. Ma L, Fogo AB (2001) Role of angiotensin II in glomerular injury. Semin Nephrol 21:544-553
2. Wiecek A, Chudek J, Kokot F (2003) Role of angiotensin II in the progression of diabetic nephropathy-therapeutic implications. Nephrol Dial Transplant 18(Suppl 5):v16-v20
3. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril insensitive carboxypeptidase. J Biol Chem 275:33238-33243
4. Donoghue M, Hsieh F, Baronas E et al (2000) Novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87:E1-E9
5. Ingelfinger JR (2006) ACE2: a new target for prevention of diabetic nephropathy? J Am Soc Nephrol 17:2957-2959
6. Chappel MC, Ferrario CM (2006) ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7). Kidney Int 70:8-10
7. Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, Batlle D (2004) Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 43:1120-1125
8. Wysocki J, Ye M, Soler MJ et al (2006) ACE and ACE2 activity in diabetic mice. Diabetes 55:2132-2139
9. Anderson S, Jung FF, Ingelfinger JR (1993) Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 265:F477-F486
10. Tikellis C, Johnston CI, Forbes JM et al (2003) Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41:392-397
11. Ferrario CM, Jessup J, Chappell MC (2005) Effect of angiotensin- converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111:2605-2610
12. Ferrario CM, Jessup J, Gallagher PE (2005) Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int 68:2189-2196
13. Li B, Hartono C, Ding R et al (2001) Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 344:947-954
14. Szeto CC, Chow KM, Lai KB et al (2006) mRNA expression of target genes in the urinary sediment as a noninvasive prognostic indicator of CKD. Am J Kidney Dis 47:578-586
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461-470
16. Mitch WE (1986) Measuring the rate of progression of renal insufficiency. In: Mitch WE (ed) The progressive nature of renal disease. Churchill Livingstone, New York, pp 203-220
17. Szeto CC, Chan RW, Lai KB et al (2005) Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. Nephrol Dial Transplant 20:105-113
18. Applied Biosystems (2004) Guide to performing relative quantitation of gene expression using real-time quantitative PCR. Applied Biosystems, Foster City, CA
19. Applied Biosystems (2004) Amplification efficiency of TaqManÒ gene expression assays. Applied Biosystems, Foster City, CA
20. Santos RA, Ferreira AJ (2007) Angiotensin-(1-7) and the renin-angiotensin system. Curr Opin Nephrol Hypertens 16:122-128
21. Oudit GY, Herzenberg AM, Kassiri Z et al (2006) Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 168:1808-1820
22. Harris RC, Cheng HF (1996) The intrarenal renin-angiotensin system: a paracrine system for the local control of renal function separate from the systemic axis. Exp Nephrol 4(Suppl 1):2-7
23. Gilbert RE, Wu LL, Kelly DJ et al (1999) Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol 155:429-440
24. Nishiyama A, Seth DM, Navar LG (2002) Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol 13:2207-2212
25. Ruster C, Wolf G (2006) Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17:2985-2991
26. Williams ME (2005) Diabetic nephropathy: the proteinuria hypothesis. Am J Nephrol 25:77-94
27. Wakahara S, Konoshita T, Mizuno S et al (2007) Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE/ACE2 ratio. Endocrinology 148:2453-2457
28. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D (2006) Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 17:3067-3075
29. Konoshita T, Wakahara S, Mizuno S et al (2006) Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care 29:848-852
30. Lely AT, Hamming I, van Goor H, Navis GJ (2004) Renal ACE2 expression in human kidney disease. J Pathol 204:587-593
31. Shaltout HA, Westwood BM, Averill DB et al (2007) Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 292:F82-F91
32. Jessup JA, Gallagher PE, Averill DB et al (2006) Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. Am J Physiol Heart Circ Physiol 291:H2166-H2172